199 related articles for article (PubMed ID: 3522723)
1. [Preoperative dilatation of the cervix uteri by vaginal application of 9-deoxo-16, 16-dimethyl-9-methylene PGE2 in pregnancy interruption during the 1st trimester. Double-blind clinical study].
Friedli A; De Grandi P
J Gynecol Obstet Biol Reprod (Paris); 1986; 15(2):215-21. PubMed ID: 3522723
[TBL] [Abstract][Full Text] [Related]
2. [Preoperative cervix dilatation in 1st trimester pregnancy interruption using 9-deoxy-16, 16-dimethyl-9-methylene prostaglandin E2. A randomized double-blind study].
Brügger D; Dreher E
Geburtshilfe Frauenheilkd; 1985 Aug; 45(8):567-9. PubMed ID: 4043711
[TBL] [Abstract][Full Text] [Related]
3. Low-dose prostaglandin E2 analogue for cervical dilatation prior to pregnancy termination.
Borten M; DiLeo LA; Friedman EA
Am J Obstet Gynecol; 1984 Nov; 150(5 Pt 1):561-5. PubMed ID: 6496588
[TBL] [Abstract][Full Text] [Related]
4. Cervical dilatation with meteneprost vaginal suppositories in first trimester abortion.
Somell C; Olund A
Contraception; 1986 Feb; 33(2):189-94. PubMed ID: 3698595
[TBL] [Abstract][Full Text] [Related]
5. [Cervical dilatation by use of a vaginal suppository of meteneprost before voluntary interruption of the pregnancy in the first trimester].
Maria B; André-David F; Oury JF; Stampf F; Bresson E; Rosenberg P
J Gynecol Obstet Biol Reprod (Paris); 1987; 16(5):637-42. PubMed ID: 3668189
[TBL] [Abstract][Full Text] [Related]
6. [Use of a new vaginal suppository: prostaglandin E1 analog Gemeprost for cervix maturation prior to abortion in the 1st trimester].
Rabe T; Helk J; Kiesel L; Zwick J; Runnebaum B
Geburtshilfe Frauenheilkd; 1985 Jun; 45(6):393-401. PubMed ID: 3894147
[TBL] [Abstract][Full Text] [Related]
7. Pre-abortion treatment with a single vaginal suppository containing 9-deoxo-16,16-dimethyl-9-methylene PGE2 in late first and early second trimester pregnancies.
Moberg PJ; Bygdeman M; Carnsjö LG; Frankman O; Gréen K
Acta Obstet Gynecol Scand Suppl; 1983; 113():137-40. PubMed ID: 6574668
[TBL] [Abstract][Full Text] [Related]
8. Preabortion cervical dilatation with a low-dose prostaglandin suppository. A comparison of two analogs.
Lauersen NH; Graves ZR
J Reprod Med; 1984 Feb; 29(2):133-5. PubMed ID: 6708030
[TBL] [Abstract][Full Text] [Related]
9. A comparison of two stable prostaglandin E analogues for termination of early pregnancy and for cervical dilatation.
Bygdeman M; Bremme K; Christensen N; Lundström V; Gréen K
Contraception; 1980 Nov; 22(5):471-83. PubMed ID: 7471738
[TBL] [Abstract][Full Text] [Related]
10. Mid-trimester abortion by vaginal administration of 9-deoxo-16, 16-dimethyl-9-methylene-PGE2.
Bygdeman M; Christensen N; Gréen K; Lundström V
Contraception; 1980 Aug; 22(2):153-64. PubMed ID: 7449380
[TBL] [Abstract][Full Text] [Related]
11. A randomized double blind study of a new ready-for use prostaglandin gel (Org 2436) for cervical ripening prior to first trimester pregnancy termination.
Osmers R; Rath W; Conrad A; Kuhn W
Zentralbl Gynakol; 1990; 112(9):545-54. PubMed ID: 2378185
[TBL] [Abstract][Full Text] [Related]
12. Effects of prostaglandin E2 analogue suppository on blood loss in suction abortion.
Sidhu MS; Kent DR
Obstet Gynecol; 1984 Jul; 64(1):128-30. PubMed ID: 6738937
[TBL] [Abstract][Full Text] [Related]
13. Intravaginal administration of 9-deoxo-9-methylene-16,16-dimethyl PGE2 for cervical dilation prior to suction curettage.
Shapiro AG; Lasseter K; Cobiella A; Domenzain M
Int J Gynaecol Obstet; 1982 Apr; 20(2):137-40. PubMed ID: 6125434
[TBL] [Abstract][Full Text] [Related]
14. Development of a vaginal gel containing 9-deoxo-16,16-dimethyl-9-methylene PGE2 for cervical dilatation and pregnancy termination.
Gréen K; Bygdeman M; Swahn ML; Vesterqvist O; Christensen NJ
Prostaglandins Leukot Essent Fatty Acids; 1988 Aug; 33(2):121-7. PubMed ID: 3174718
[TBL] [Abstract][Full Text] [Related]
15. Cervical dilatation in the nonpregnant patient with vaginal 16-dimethyl prostaglandin E2.
Nuss RC; Baird T; Benrubi G; Thompson RJ
J Fla Med Assoc; 1985 Jun; 72(6):426-7. PubMed ID: 4045400
[No Abstract] [Full Text] [Related]
16. A Gemeprost vaginal suppository for cervical priming prior to termination of first trimester pregnancy.
Kajanoja P; Mandelin M; Mäkilä UM; Ylikorkala O; Felding C; Somell C; Olund A; Pedersen H
Contraception; 1984 Mar; 29(3):251-60. PubMed ID: 6539662
[TBL] [Abstract][Full Text] [Related]
17. Cervical dilatation with 16,16-dimethyl-trans-delta 2-PGE1 methyl ester (Cervagem) prior to vacuum aspiration. A double-blind, placebo-controlled randomized study.
Christensen NJ; Bygdeman M
Contraception; 1984 May; 29(5):457-64. PubMed ID: 6378517
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin vaginal suppositories in non pregnant women requiring cervical dilatation prior to hysteroscopy.
Hald F; Kristoffersen SE; Gregersen E
Acta Obstet Gynecol Scand; 1988; 67(3):219-22. PubMed ID: 3051874
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of various intracervically administered PG gel preparations for termination of first trimester pregnancies.
Rath W; Meyer D; Hildebrandt J; Hilgers R; Kuhn W
Contraception; 1983 Sep; 28(3):209-22. PubMed ID: 6357631
[TBL] [Abstract][Full Text] [Related]
20. The cervix-ripening effect of 15-methyl-prostaglandin F2 alpha methyl ester before vacuum aspiration for termination of early pregnancy in primigravidae.
Wang YF; Jin YC; Wu YE; Gu LJ; Xie XH
Chin Med J (Engl); 1989 Mar; 102(3):200-2. PubMed ID: 2503307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
